Page last updated: 2024-10-23

aspirin and Lipid Metabolism, Inborn Error

aspirin has been researched along with Lipid Metabolism, Inborn Error in 1 studies

Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lockman, LA1
Hunninghake, DB1
Krivit, W1
Desnick, RJ1

Trials

1 trial available for aspirin and Lipid Metabolism, Inborn Error

ArticleYear
Relief of pain of Fabry's disease by diphenylhydantoin.
    Neurology, 1973, Volume: 23, Issue:8

    Topics: Adolescent; Adult; Aspirin; Ceramides; Clinical Trials as Topic; Evaluation Studies as Topic; Female

1973